Proteomic analysis of ascitic extracellular vesicles describes tumour microenvironment and predicts patient survival in ovarian cancer
Anna Vyhlídalová Kotrbová,Kristína Gömöryová,Antónia Mikulová,Hana Plešingerová,Stanislava Sladeček,Marek Kravec,Šárka Hrachovinová,David Potěšil,Garett Dunsmore,Camille Blériot,Mathilde Bied,Jan Kotouček,Markéta Bednaříková,Jitka Hausnerová,Luboš Minář,Igor Crha,Michal Felsinger,Zbyněk Zdráhal,Florent Ginhoux,Vít Weinberger,Vitězslav Bryja,Vendula Pospíchalová
DOI: https://doi.org/10.1002/jev2.12420
2024-03-16
Journal of Extracellular Vesicles
Abstract:We performed the first in‐depth proteomics study of precisely isolated EVs from ascites of HGSC patients and identified core ascitic EV‐associated proteins as well as HGSC‐specific EV‐associated proteins. We provide evidence that by the combination of EV proteomics and single‐cell methods, we can assess the contribution of cells forming the tumour and its environment to EV pool in the ascites. Surprisingly, analysis of cell‐type specific EV markers showed a stronger predictive potential for HGSC patient survival than analysis of ascitic cells. High‐grade serous carcinoma of the ovary, fallopian tube and peritoneum (HGSC), the most common type of ovarian cancer, ranks among the deadliest malignancies. Many HGSC patients have excess fluid in the peritoneum called ascites. Ascites is a tumour microenvironment (TME) containing various cells, proteins and extracellular vesicles (EVs). We isolated EVs from patients' ascites by orthogonal methods and analyzed them by mass spectrometry. We identified not only a set of 'core ascitic EV‐associated proteins' but also defined their subset unique to HGSC ascites. Using single‐cell RNA sequencing data, we mapped the origin of HGSC‐specific EVs to different types of cells present in ascites. Surprisingly, EVs did not come predominantly from tumour cells but from non‐malignant cell types such as macrophages and fibroblasts. Flow cytometry of ascitic cells in combination with analysis of EV protein composition in matched samples showed that analysis of cell type‐specific EV markers in HGSC has more substantial prognostic potential than analysis of ascitic cells. To conclude, we provide evidence that proteomic analysis of EVs can define the cellular composition of HGSC TME. This finding opens numerous avenues both for a better understanding of EV's role in tumour promotion/prevention and for improved HGSC diagnostics.
cell biology
What problem does this paper attempt to address?